论文部分内容阅读
谈到原发性肝细胞癌(HCC),大家都知道是威胁生命的恶性肿瘤之一,对乙肝病毒感染者来说更是毛骨悚然。因为在世界范围内HCC已是位居第三的肿瘤相关性致死性原因。目前HCC年发生人数已超过62.6万,在全球的发病率逐年增长,我国发病人数约占全球的55%,其发病率和肿瘤相关死亡率均在我国位居第二。由于我国乙肝病毒感染率高,因此由乙型肝炎病毒(HBV)感染导致的原发性肝细胞癌约占70%左右,对乙肝病毒感染者而言是独立的危险因素。尽管手术切除HCC一直被认为是可能治愈的唯一方法,但70%~80%的患者在确诊HCC时多已为中晚期,或因肝硬化程度重、或肿瘤位置临近大血管、侵犯血管或存在肝外转移等因素,失
Speaking of primary hepatocellular carcinoma (HCC), we all know that one of the life-threatening malignancies is even more horrifying to people with hepatitis B virus infection. Because HCC is the third leading cause of tumor-related deaths in the world. At present, the number of HCCs has exceeded 626,000. The incidence of HCC in the world has been increasing year by year. The incidence of HCC in China accounts for about 55% of the global total. The incidence and the incidence of cancer-related deaths are the second in China. Due to the high rate of hepatitis B virus infection in our country, about 70% of primary hepatocellular carcinoma caused by Hepatitis B virus (HBV) infection is an independent risk factor for hepatitis B virus infection. Although surgical resection of HCC has long been considered as the only possible cure, 70% to 80% of patients are diagnosed with advanced HCC or advanced cirrhosis, or have neoplasms near the tumor, vascular invasion or presence Extrahepatic metastasis and other factors, loss